title: [How can PET scan be used in Parkinson disease?].
abstract: PET (positron emission tomography) has yielded manifest improvements in our knowledge of Parkinson's disease, in terms of pathological and pharmacological aspects. Since PET was introduced in study of Parkinson's disease 15 years ago, the technique has been steady refined, and more tracers are becoming available. The possibility of monitoring the dopamine system in longitudinal studies will no doubt become cornerstone in the evaluation of neuroprotective therapies.
authors.affiliation: Neurologiska kliniken, Akademiska sjukhuset, Uppsala.
authors.forename: J
authors.initials: J
authors.lastname: Tedroff
mesh_terms: D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use; D010300:Parkinson Disease / Q000175:diagnosis* / Q000628:therapy; D011954:Receptors, Dopamine / Q000502:physiology; D014055:Tomography, Emission-Computed
chemical_list: D018696:Neuroprotective Agents; D011954:Receptors, Dopamine
vernacular_title: Hur kan PET användas kliniskt vid Parkinson's sjukdom?